Cynata Therapeutics – Producing Stem Cells for Regenerative Medicine
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 27 April 2017
⏱️ 32 minutes
🧾️ Download transcript
Summary
Dr Kilian Kelly, Vice President, Cynata talks about Cymerus™. A platform for stem cell technology based upon extremely important and versatile stem cells known as mesenchymoangioblasts (MCAs). MCAs are a predecessor of mesenchymal stem (or stromal) cells (MSCs) which are being examined for such diseases such as osteoarthritis, Crohn's disease and heart disease.
Kilian talks about utilizing iPSCs originating from an adult donor as the preliminary material for producing MCAs and in turn for manufacturing the MSC therapeutic product. This opens up a wide range of therapeutic and manufacturing possibilities for the Company.
The Cymerus™ technology has numerous features that makes it perfect for the growth of cell-based therapeutics. This has the potential to create a new standard in the emergent arena of regenerative medicine and stem cell therapeutics and provides Cynata with both a unique differentiator and an important competitive position.
Listen, subscribe and share to help our podcasting efforts. Contribute Bitcoin to fuel our interviews and keep us going!
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Almost Here, Around the Corner of Future Technology Podcasts with Richard Jacobs. |
| 0:07.9 | Future Technologies are poised to transform our lives for better or worse for the focus of this podcast. |
| 0:13.6 | Almost here means these technologies are now here and starting to be used. |
| 0:18.2 | We're just around the corner. |
| 0:19.7 | From Bitcoin to artificial intelligence, |
| 0:22.0 | 3D printing, blockchain, virtual reality, and more. |
| 0:26.3 | Hi, this is Richard Jacobs with Future Tech Podcast, almost here, round-the-corner technologies. |
| 0:33.1 | Today I've got an interesting interview with Killian Kelly, |
| 0:35.9 | vice president of products at Sinata Therapeutics. |
| 0:40.0 | How are you doing, Killian? |
| 0:41.9 | I'm doing really well, thanks. How are you? |
| 0:45.4 | Good. Where are you hailing out of? Where are you today? |
| 0:49.4 | So I'm in Melbourne, Australia, which is where Sinada is based. |
| 0:55.2 | So we are headquartered here in Melbourne, Australia, although we do have activities |
| 1:01.4 | kind of going on in various places around the world, including the US. |
| 1:08.3 | Well, very good. Can you give folks a brief description of what Sinata does? |
| 1:11.6 | Sure. So, Sinada is a stem cell and regenerative medicine company. So it was founded just a few years ago, and specifically to develop a new type of manufacturing technology to mass produce stem cells for therapeutic purposes. |
| 1:33.4 | In other words, to develop new medical treatment. |
| 1:37.2 | And the technology originated from the University of Wisconsin in Madison. |
| 1:42.0 | But as I said, the company is now headquartered in Australia and we're moving some of these |
| 1:48.9 | products forward. |
| 1:50.3 | We have recently commenced our first clinical trial in human patients. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.